Elixir Capital Ltd. schedules board meeting for February 13, 2026 to consider Q3FY26 unaudited financial results

1 min read     Updated on 03 Feb 2026, 03:27 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Elixir Capital Ltd. has scheduled a board meeting for February 13, 2026, at 4:00 p.m. to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2025. The company has closed its trading window from January 1, 2026, which will reopen 48 hours after the financial results declaration. This announcement was made in compliance with SEBI (LODR) Regulations, 2015, and communicated to BSE Limited where the company is listed under scrip code 531278.

31658242

*this image is generated using AI for illustrative purposes only.

Elixir Capital Ltd. has announced that its board of directors will convene on February 13, 2026, to review and approve the company's quarterly financial performance. The meeting, scheduled for 4:00 p.m. at the company's registered office, will focus on the unaudited financial results for the quarter and nine months ended December 31, 2025.

Board Meeting Details

The board meeting has been convened in accordance with Regulation 29(1)(a) of the SEBI (LODR) Regulations, 2015. The primary agenda items for the meeting include:

Agenda Item: Details
Financial Results Review: Unaudited financial results (standalone and consolidated) for Q3FY26
Period Covered: Quarter and nine months ended December 31, 2025
Meeting Date: February 13, 2026
Meeting Time: 4:00 p.m.
Venue: Registered office of the company

The board will also consider any other business matters with the permission of the chairperson during the meeting.

Trading Window Closure

Elixir Capital Ltd. has implemented a trading window closure as part of its compliance with insider trading regulations. The company previously notified the exchange on December 26, 2025, regarding this closure.

Parameter: Details
Closure Start Date: January 1, 2026
Reason: Consideration of unaudited financial results
Reopening: 48 hours after declaration of financial results
Applicable Period: Quarter and nine months ended December 31, 2025

Regulatory Compliance

The announcement demonstrates the company's adherence to regulatory requirements under SEBI (LODR) Regulations, 2015. The notice was formally communicated to BSE Limited, where the company's shares are listed under scrip code 531278. The communication was signed by Radhika Mehta, Whole-Time Director of Elixir Capital Limited, and dated February 3, 2026.

The company, formerly known as Axis Capital Markets India Ltd., continues to maintain transparency in its corporate governance practices through timely disclosure of material information to stakeholders and regulatory authorities.

Historical Stock Returns for Elixir Capital

1 Day5 Days1 Month6 Months1 Year5 Years
+1.19%-0.28%+1.78%-7.74%-55.26%+266.67%
1 Year Returns:-55.26%